Krebs Biochemicals and Industries has informed that the meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 13th February 2018 at Hyderabad to consider and approve the unaudited financial results along with the Limited Review Report for the quarter ended 31st December, 2017; and any other matter with the permission of the Chair. Further, in connection to the declaration of unaudited financial results, trading window for dealing in shares of the Company will remain closed for the specified persons as defined in the Code from 6th February 2018 and shall re-open 48 hours after the publication of the results to the public.
The above information is a part of company’s filings submitted to BSE.
